Alcon Google Innovation
4 likes1,805 views
1) Alcon and Google have partnered to develop "smart lens" technology to address unmet medical needs in eye care, such as treating cataracts, age-related macular degeneration, glaucoma, and presbyopia. 2) The collaboration aims to create glucose-sensing contact lenses to help diabetics manage their condition, and accommodating contact lenses or IOLs to restore near vision for presbyopes. 3) While smart lenses offer advantages like ease of use and data sharing, challenges include ensuring patient privacy as health data is collected and regulatory hurdles in approving new mobile medical devices.
![[X] Marks the Spot...](https://image.slidesharecdn.com/franck-160204210822/85/Alcon-Google-Innovation-4-320.jpg)
Alcon Google Innovation
- 1. Alcon – Google Innovation: Visions of Ophthalmology in 2020 Moderated By: Panel Participants:
- 2. a Novartis company Future Technology in Eye Care Franck Leveiller Vice President, Head R&D Surgical franchise Alliance Manager Alcon-Google partnership
- 3. The Intersection of the Eye and Technology
- 4. [X] Marks the Spot...
- 5. In July 2014, Novartis and Google announced collaboration...
- 6. Alcon focus is to address unmet medical needs for patients in eye care... by potentially applying “smart lens” technology • 20 million blind from treatable cataracts1 • 25 million with AMD2 • 67 million with glaucoma3 • 1.7 billion people with presbyopia4 • 90% of problems can be prevented, treated or cured1,5,6 1) International Agency for the Prevention of Blindness (IAPB), Global Facts, http://www.iapb.org/vision-2020/global-facts │ 2) World Health Organization. Vision 2020: The Right to Sight. http://www/whoint/blindness/Vision_2020_report.pdf. (Accessed September 26, 2012) │ 3) Lighthouse International. Prevalence of Vision Impairment. http://www.lighthouse.org/research/statistics-on-vision- impairment/prevalence-of-vision-impairment/. │ 4) Market Scope, Global Presbyopia-Correcting Surgery Market Report, April 2012 │ 5) Brien Holden Vision Institute, Vision Correction Needs, http://www.brienholdenvision.org/research/vision-correction-needs.html. │ 6) World Health Organization (WHO: Blindness: Visual Impairment and Blindness. (Updated June 2012) http://www.who.int/mediacentre/factsheets/fs282/en/index.html (Accessed March 29, 2013)
- 7. Novartis Interest in the Google “Smart Lens” Technology Currently Focused in Two Areas Helping diabetic patients manage their disease by providing a continuous, minimally invasive measurement of the body’s glucose levels via a “smart contact lens” For people living with presbyopia who can no longer read without glasses, the “smart lens” has the potential to help restore the eye’s natural focusing ability on near objects 1. Ophthalmic Biosensing 2. Functional Improvement
- 8. Alcon-Google Collaboration Can Transform Eye Care • “10x mindset” and passion • Ultra-fast prototyping • Miniaturization excellence Glucose-sensing Contact Lens Accommodating Contact Lens Accommodating IOL • Medical device leadership • Deep pharmaceuticals expertise
- 9. While Many Possible Configurations Exist, the Goal is to Empower Actions with Data Smart Lens Mobile Storage/ Analytics Sensor data/config Actionable feedback
- 10. Upcoming Biosensor Challenges • Patient Privacy – Despite the many advantages (ease of use, sharing data with HCPs, potential for analytics, etc.), some patients may not be comfortable with personal health data being stored on cloud-based systems – Additionally, concerns may arise around healthcare payers using personal health data to potentially deny reimbursement of medical expenses • Regulatory Issues – Agencies will need to continually adapt regulations on mobile medical applications to support innovative ways to enhance health and healthcare delivery – Multiple branches of Regulatory bodies will need to work together to thoroughly review “smart device” submissions
- 11. We’ve Barely Tipped the Innovation Scale • Our eyes are the window into the body’s systemic conditions • The promising impact of innovation spurs continued investment • Innovation is critical in ensuring healthy vision as we age • The merger of technology and healthcare will provide improved patient outcomes